Imunon (CLSN) News Today → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free CLSN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineImunon Inc IMNNmorningstar.com - March 10 at 7:09 PMCLSN.L Regulatory Newslse.co.uk - May 22 at 5:10 PMCelsion Corporation Advances Proof of Concept to Non-human Primate Challenge Study Against SARS-CoV-2 with In-Process Vaccine Candidate - Marketscreener.commarketscreener.com - October 9 at 3:20 PMImunon Reports Partial Results from Ongoing Non-human Primate Study - GlobeNewswireglobenewswire.com - October 3 at 10:12 PMImunon Appoints James E. Dentzer to its Board of Directors - GlobeNewswireglobenewswire.com - October 3 at 5:11 PMImunon Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4) - GlobeNewswireglobenewswire.com - September 29 at 7:48 PMIMUNON to Present at Chardan's 6th Annual Genetic Medicines - GlobeNewswireglobenewswire.com - September 28 at 2:13 AMCelsion Corporation Announces Company Name Change to Imunon, Inc. - GlobeNewswireglobenewswire.com - September 19 at 6:40 PMCelsion Corporation Announces Company Name Change to Imunon, Inc.finance.yahoo.com - September 19 at 6:39 PMCelsion Completes Enrollment of the Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer - GlobeNewswireglobenewswire.com - September 15 at 2:07 PMCelsion Completes Enrollment of the Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancerfinance.yahoo.com - September 15 at 2:07 PMCelsion (NASDAQ:CLSN) – Celsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global I - Benzingabenzinga.com - September 12 at 7:21 PMCelsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global Investment Conference Changed to 4:30 p.m. ET on September 13finance.yahoo.com - September 12 at 7:21 PMCelsion (NASDAQ:CLSN) – Celsion Earnings Perspective: Return On Capital Employed - Benzingabenzinga.com - September 9 at 6:30 PMCelsion Earnings Perspective: Return On Capital Employedmsn.com - September 9 at 1:29 PMCelsionoration (CLSN) – Celsion Corporation to Present at the H.C. Wainwright 24th Annual Global Investme - Benzingabenzinga.com - September 7 at 9:25 AMCelsion Corporation to Present at the H.C. Wainwright 24th - GlobeNewswireglobenewswire.com - September 7 at 9:25 AMCelsion Corporation to Present at the H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 7 at 9:25 AMCLSN.OQ - Celsion Corporation | Stock Price & Latest News | Reutersreuters.com - September 5 at 10:03 PMCelsion Corporation Highlights Progress in its DNA-based Vaccine Program - GlobeNewswireglobenewswire.com - September 1 at 12:44 PMCelsion Corporation Highlights Progress in its DNA-based Vaccine Programfinance.yahoo.com - September 1 at 12:44 PMCLSN: Complete Enrollment of OVATION 2 Study Expected in 3Q22…finance.yahoo.com - August 30 at 12:03 PMCelsion GAAP EPS of -$0.87, revenue of $0.13M - Seeking Alphaseekingalpha.com - August 15 at 11:57 AMCELSION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q) - Marketscreener.commarketscreener.com - August 15 at 11:57 AMRecap: Celsion Q2 Earnings - Benzingabenzinga.com - August 15 at 11:57 AMCelsion Corporation Reports Second Quarter 2022 Financial Results and Provides Business Update - GlobeNewswireglobenewswire.com - August 15 at 11:57 AMCelsion Corporation Reports Second Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - August 15 at 11:57 AMCelsion Q2 2022 Earnings Previewseekingalpha.com - August 14 at 8:53 PMCelsion Corporation to Hold Second Quarter 2022 Financial Results and Business Update Conference Call on Monday, August 15, 2022 - GlobeNewswireglobenewswire.com - August 9 at 12:51 PMCelsion Corporation to Hold Second Quarter 2022 Financial Results and Business Update Conference Call on Monday, August 15, 2022finance.yahoo.com - August 8 at 4:50 PMCelsion Appoints Corinne Le Goff To Succeed Michael Tardugno As President And CEOnasdaq.com - July 21 at 5:49 AMU.S. Stocks May Move Back To The Upside After Yesterday's Downturn - Nasdaqnasdaq.com - July 19 at 3:58 PMNasdaq Bear Market: 1 Growth Stock Down More Than 90% to Buy Now - Nasdaqnasdaq.com - July 19 at 3:58 PMCelsion Appoints Dr. Corinne Le Goff as President and Chief Executive Officer - GlobeNewswireglobenewswire.com - July 19 at 9:11 AMCelsion Appoints Dr. Corinne Le Goff as President and Chief Executive Officerfinance.yahoo.com - July 19 at 9:11 AMCelsion Corporation Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)finance.yahoo.com - July 19 at 9:11 AMCelsion Reports Data Safety Monitoring Board Unanimous Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer - GlobeNewswireglobenewswire.com - June 21 at 11:54 AMCelsion Corporation Highlights Pipeline Progress in Its Lead Development Candidates - GuruFocus.comgurufocus.com - June 20 at 5:50 AMCLSN: OVATION 2 Study 85% Enrolled… - Benzinga - Benzingabenzinga.com - June 18 at 11:55 AMCELSION CORP : Submission of Matters to a Vote of Security Holders (form 8-K) - Marketscreener.commarketscreener.com - June 14 at 12:40 PMCLSN: OVATION 2 Study 85% Enrolled…finance.yahoo.com - June 13 at 4:02 PMGlobal Nucleic Acid Based Gene Therapy Market to 2031 - Featuring BioMedica, Transgene and Copernicus Therapeutics Among Others - ResearchAndMarkets.com - Business Wirebusinesswire.com - June 9 at 10:51 AMNucleic Acid Based Gene Therapy Global Market Report 2022 - Yahoo Financefinance.yahoo.com - May 30 at 7:09 AMAdvanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression - StreetInsider.comstreetinsider.com - May 20 at 3:23 PMCelsion Corporation Reports First Quarter 2022 Financial Results and Provides Business Update - GlobeNewswireglobenewswire.com - May 17 at 12:18 PMCelsion: Q1 Earnings Insights - Benzinga - Benzingabenzinga.com - May 16 at 9:17 PMEarnings Outlook For Celsionbenzinga.com - May 14 at 4:52 AMCelsion Q4 2022 Earnings Previewseekingalpha.com - May 14 at 4:52 AMCelsion Corporation to Hold First Quarter 2022 Financial Results and Business Update Conference Call on Monday, May 16, 2022 - StreetInsider.comstreetinsider.com - May 11 at 9:09 AMCelsion Corporation Highlights Pipeline Progress in Its Lead Development Candidates - GlobeNewswireglobenewswire.com - May 10 at 12:37 PM Get Imunon News Delivered to You Automatically Sign up to receive the latest news and ratings for CLSN and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy CLSN Media Mentions By Week CLSN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLSN News Sentiment▼0.000.34▲Average Medical News Sentiment CLSN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLSN Articles This Week▼00▲CLSN Articles Average Week Get Imunon News Delivered to You Automatically Sign up to receive the latest news and ratings for CLSN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ABVC News Today EDSA News Today NNVC News Today AVTX News Today TNXP News Today NRBO News Today MIRA News Today RDHL News Today AYTU News Today KPRX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLSN) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imunon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
